See other companies on Welcome to the Jungle
CMR Surgical
Robotic systems for minimal access surgery
- 501-1000 employees
- Healthcare
- B2B
- Robotics
- Data Analysis
- MedTech
- Milton, UK
Jump to section
Company mission
CMR Surgical's mission is to deliver an evidence based approach to surgical robotics, empowering surgeons, surgical teams and hospitals to transform how surgery is performed across the world.
Our take
Minimal access surgery holds great benefits for both surgeons and patients, but there is only so much that surgeons can achieve with just a steady hand. Robotic technology shows a great track record for augmenting the capabilities of surgeons, but existing minimal access solutions are highly specialist and therefore only useful in very specific scenarios.
CMR Surgical develops a robotic system for minimal access surgery called Versius, designed to be highly versatile to tackle a wide range of complex procedures with precision. The robotic system leverages a digital interface to facilitate real-time data-driven insights within the operating room, along with a user interface to facilitate real-time robotic changes.
Whilst CMR Surgical will face challenges from other surgery robotic systems, the company stands out with its approach to robotic versatility and real-time data analytics, in addition to finding a niche in minimal access surgery. Through its focus on flexibility, the company aims to increase access to surgical robotics whilst ensuring that only one robot system is required for all minimal access surgical procedures.
Steph
Company Specialist at Welcome to the Jungle
Company values
- People focused - We care about our patients, customers and colleagues. We respect and value each other’s opinions and are an inclusive workplace. The wellbeing o
- Ambitious - To serve patients and transform surgery, we must be a successful, growing, global, medical devices company
- Humble - We strive to be self-aware. We take nothing for granted, admit mistakes and seek to understand and improve
- Fair & Responsible - We have a duty of care to our patients, customers and colleagues. We are honest and behave in an ethical and transparent manner
Funding (last 2 of 6 rounds)
Sep 2023
$165m
LATE VC
Jun 2021
$600m
SERIES D
Total funding: $1.2bn
This company has top investors
Leadership
Per Vegard Nerseth
(CEO, not founder)Experience as President of ABB Engineering from 2005 to 2007. Group Senior Vice President for ABB Ltd. from 2007 to 2019.
Mark Slack
(CMO & Co-founder)Experience as Consultant Gynaecologist at the Cambridge University Hospitals NHS Foundation Trust from 2001 to 2018. Associate Lecturer at the University of Cambridge since 2001.
Luke Hares
(CTO & Co-founder)Experience as Principal Engineer and Co-founder of Cambridge Consultants from 2004 to 2010. Senior Consultant for Sagentia from 2010 to 2014.